Invex Therapeutics Seeks Shareholder Approval for New Auditor
Company Announcements

Invex Therapeutics Seeks Shareholder Approval for New Auditor

Invex Therapeutics Ltd. (AU:IXC) has released an update.

Invex Therapeutics Ltd has announced an addendum to their upcoming annual general meeting, including a new resolution for shareholders to confirm the appointment of BDO Audit Pty Ltd as the company’s auditor. This move requires shareholders to update their proxy forms if they wish to vote on the additional resolution. The board recommends a favorable vote, signaling confidence in BDO’s continued role in auditing the company.

For further insights into AU:IXC stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App